Literature DB >> 4774079

Clinical pharmacology of tobramycin.

N Horikoshi, M Valdivieso, G P Bodey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4774079     DOI： 10.1097/00000441-197312000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  7 in total

1.  Radioimmunoassay of iodinated tobramycin.

Authors:  A Broughton; J E Strong; L K Pickering; G P Bodney
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

2.  Feasibility of administering aminoglycoside antibiotics by continuous intravenous infusion.

Authors:  G P Bodey; H Y Chang; V Rodriguez; D Stewart
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

3.  Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits.

Authors:  D N Gerding; W H Hall; E A Schierl; R E Manion
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

Review 4.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

5.  Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.

Authors:  T J Marrie; M J Gurwith; A R Ronald; H G Stiver; B Lank; L Fox
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

6.  Pharmacokinetic assessment of netilmicin in newborns and older children.

Authors:  T Bergan; H Michalsen
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Pharmacokinetic studies with dibekacin, a new aminoglycoside, after intravenous and intramuscular administration to human volunteers.

Authors:  M Goto; M Sugiyama; T Ishizaki
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.